Navigation Links
Unigene and Tarix Pharmaceuticals Enter Definitive Licensing Agreement for "Peptelligence-Engineered" TXA127
Date:11/27/2012

g even if successfully developed and approved  Tarix's development of PanCyte.  These forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various risk factors. These known and unknown risk factors include, but are not limited to, the risk factors discussed in our Securities and Exchange Commission ("SEC") filings, including our annual report on Form 10-K and our quarterly reports on Form 10-Q. Words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "potential," "continue," and variations of these words (or negatives of these words) or similar expressions, are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements. In addition, any statements that refer to expectations, projections, contingencies, goals, targets or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements and are not statements of historical fact. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the SEC, we are under no obligation to publicly update or revise any forward-looking statements after the date of this release.

For Investors & Media:
Joshua Drumm, Ph.D. / Jason Rando
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jdrumm@tiberend.com
jrando@tiberend.com


'/>"/>
SOURCE Unigene Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Unigene to Announce Third Quarter 2012 Financial Results on November 20, 2012
2. Unigene To Present at the 2012 Obesity Societys 30th Annual Scientific Meeting
3. Unigene and Tarix Pharmaceuticals Report Highly Increased Oral Bioavailability of "Peptelligence-engineered" TXA127
4. Unigene Provides Update Following Recent EMA Recommendation on Calcitonin-Containing Medicines
5. Unigenes Oral PTH Phase 2 Proof-of-Concept Data to be Presented at Upcoming Scientific Conferences
6. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
7. Unigene to Present at TIDES 2012
8. Actinium Pharmaceuticals Sponsors Webinar on Clinical Use of Alpha Immunotherapy
9. Edison Pharmaceuticals Closes $20M Series F Financing
10. Valeant Pharmaceuticals Announces Publication of Efinaconazole Phase III Results
11. Zacks Sell List Highlights: J.C. Penney, Spirit AeroSystems Holdings, The New York Times and Jazz Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... NEW YORK , Jan. 15, ... new market research report is available ... Global Markets and Technologies for ... on Routes of Administration ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014 HeartWare ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that it expects revenues for the fourth ... expected full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led by ... a premier and affordable laser tattoo removal experience with the ... focus is in providing high quality cosmetic services with cutting edge ... " Southern California has seen a dramatic ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... N.C., Jan. 5, 2011 Cempra Pharmaceuticals announced ... President of Business Development.  Mr. Foster will be ... company,s two lead antibiotic programs, the next-generation fluoroketolide ... development for community-acquired bacterial pneumonia (CABP), and TAKSTATM ...
... 4, 2011 HeartWare International, Inc. (Nasdaq: ... invasive, miniaturized circulatory support technologies that are revolutionizing the ... Doug Godshall is scheduled to make an investor presentation ... 1:30 p.m. Pacific Time on Monday, January 10, 2011. ...
Cached Medicine Technology:Cempra Pharmaceuticals Names Carl Foster Executive Vice President of Business Development 2HeartWare to Present at the 29th Annual J.P. Morgan Healthcare Conference 2
(Date:7/9/2014)... most common type of lung cancer, researchers have uncovered ... in forming tumors. The new knowledge may expand treatments ... changes already are available or are in clinical trials. ... from The Cancer Genome Atlas (TCGA), including researchers at ... Medical School and other institutions, studied tumors from 230 ...
(Date:7/9/2014)... policing injection drug users in Russia might contribute ... A study, conducted by researchers from Boston University ... with St. Petersburg Pavlov State University, sought to ... health outcomes of a cohort of HIV-positive people ... who were arrested by police were more likely ...
(Date:7/9/2014)... July 9, 2014 There has been a sharp ... Southwestern Medical Center using MyChart, the online, interactive service ... communicate with their healthcare providers, schedule appointments, and renew ... patients actively using MyChart each year increased ... increased more than 10-fold, according to a study by ...
(Date:7/9/2014)... It may smell of flatulence and have a reputation for ... dosage, hydrogen sulfide is now being being found to offer ... to stroke, heart attacks and dementia. A new compound (AP39), ... the key to future therapies, by targeting delivery of very ... places inside cells. , Scientists in Exeter have already ...
(Date:7/9/2014)... print and poor printing on prescription labels handed ... lead to errors in taking medication, according to ... CNIB (Canadian National Institute for the Blind)., The ... Journal , found that labels on prescription medications ... recommended guidelines for legibility. , By simply following ...
Breaking Medicine News(10 mins):Health News:Lung cancer study hints at new treatments 2Health News:BU researchers relate arrests with HIV risk environment 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
... information from PET to traditional CT and ... ... investment, MUNICH, Germany, Oct. 10 Siemens Healthcare, ... imaging that provides a premium imaging platform, and is ...
... ROYAL PALM BEACH, Fla., Oct. 9 This may ... Internationally,acclaimed anti-aging Doctor, Al Sears MD, has become the ... through his private practice based,in Royal Palm Beach, Florida., ... on telomere biology.,Telomeres are part of your DNA. They ...
... DENVER, Oct. 9 After a thorough review ... Services (VDSS),announced that it has selected Policy Studies ... in the Chesapeake and Hampton districts.,PSI is a ... government,clients. The contract is valued at approximately $7 ...
... Oct. 9 DogChannel.com, the premier,online destination for dog ... where visitors can find what may be ailing their ... symptom list, located at http://www.DogChannel.com/medical was,compiled by ... Ph.D. of,Rocheport, Missouri. The section contains the 40 most ...
... effect , , THURSDAY, Oct. 9 (HealthDay News) -- Non-steroidal ... for breast cancer, a new review suggests. , But ... start popping the popular painkillers, the researchers added. , ... to jump on the bandwagon and start taking aspirin ...
... DENVER, Oct. 9 The National Academy of,Neuropsychology (NAN) ... 2008 Annual Conference to be held October 22nd,through 25th ... New York, New York.,The event will kick off with ... conference on October 21, which includes an athlete panel,featuring ...
Cached Medicine News:Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4Health News:Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging 2Health News:Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging 3Health News:PSI Selected to Operate Virginia's Child Support Program in Chesapeake and Hampton 2Health News:DogChannel.com Launches Online Guide to Dog Medical Conditions 2Health News:NSAIDs Might Lower Breast Cancer Risk 2Health News:NSAIDs Might Lower Breast Cancer Risk 3Health News:National Academy of Neuropsychology to Focus on Effects of Sports Concussions at 2008 Conference 2
... ultralight and ultra versatile model angulates ... will adjust the height of the ... a single post, or double tee ... for physician comfort and stability. A ...
... powered torso and leg sections ... Table simultaneously lift body and ... mechanism raises and lowers legs ... positioning. A wide range of ...
... the surgical table to a new level ... perfect table complement for any fracture procedure. ... in the surgical process, the PROfx table ... surgeon to minimize the invasiveness of procedures ...
... Amsco OrthoVision Orthopedic and Fracture Table ... table. It provides flexible, easy to ... reconstructive and reparative orthopedic procedures. Radiolucent ... perineal post provide exceptional imaging capability. ...
Medicine Products: